S 493 S 493 Pill - red capsule/oblong, 18mm
Pill with imprint S 493 S 493 is Red, Capsule/Oblong and has been identified as Amantadine Hydrochloride 100 mg. It is supplied by Vensun Pharmaceuticals, Inc.
Amantadine is used in the treatment of Extrapyramidal Reaction; Influenza; Influenza A; Parkinson's Disease; Tardive Dyskinesia and belongs to the drug classes adamantane antivirals, dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Amantadine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for S 493 S 493
Amantadine Hydrochloride
- Imprint
- S 493 S 493
- Strength
- 100 mg
- Color
- Red
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Adamantane antivirals, Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Vensun Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 42543-0493
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
FD&C Blue No. 1,
FD&C Red No. 40,
gelatin,
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate,
titanium dioxide,
ethylcellulose (7 mPa.s),
potassium hydroxide,
propylene glycol,
shellac,
ammonia
Note: Inactive ingredients may vary.
Related images for "S 493 S 493"
More about amantadine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (52)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: adamantane antivirals
- Breastfeeding
- En español
Patient resources
- Amantadine drug information
- Amantadine Extended-Release Tablets
- Amantadine Extended-Release Capsules
Other brands
Gocovri, Symmetrel, Osmolex ER
Professional resources
- Amantadine (Antiviral) monograph
- Amantadine (FDA)
- Amantadine Oral Solution USP (FDA)
- Amantadine Syrup (FDA)
- Amantadine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
